John S. Chorba

Targeted protein degradation: advances in drug discovery and clinical practice

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake

The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Active Site and Cleavage Sequence Differentially Regulate Protein Secretion from Proteolysis